Latham & Watkins LLP has advised Neuberger Berman Capital Solutions. Weil, Gotshal & Manges LLP has advised OMERS Private Equity and Paradigm. Neuberger Berman Capital Solutions...
Neuberger Berman Capital Solutions Invests in Paradigm
BrightSpring Health Services Completes $304.5 Million Secondary Offering
Barnes & Thornburg LLP has advised BrightSpring Health Services. Latham & Watkins LLP has advised the underwriters. BrightSpring Health Services, Inc., a leading provider of home...
Alcon Inc’s Acquisition of LENSAR Inc
Norton Rose Fulbright represented Alcon Inc., Latham & Watkins represented LENSAR, Inc. in the transaction. Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated...
Boston Scientific’s Acquisition of SoniVie Ltd.
Latham & Watkins advised Boston Scientific, while K&L Gates advised SoniVie Ltd. on the transaction. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
Carlyle and SK Capital’s Acquisition of bluebird bio
Wachtell, Lipton, Rosen & Katz, Kirkland & Ellis, and Orrick, Herrington & Sutcliffe are serving as legal advisors to Carlyle and SK Capital, while Latham &...
Globus Medical’s $250 Million Acquisition of Nevro Corp.
Wyrick Robbins Yates & Ponton served as legal advisor to Globus Medical, Inc., while Latham & Watkins served as legal advisor to Nevro Corp. Fried Frank...
Qventus’ $105 Million Series D
Wilson Sonsini Goodrich & Rosati advised Qventus on the transaction, and Latham & Watkins advised KKR. Qventus, a leading provider of AI-based care automation software for...
LetsGetChecked’s Acquisition of Truepill
Goodwin Procter, McDermott Will & Emery, and Mason Hayes & Curran advised LetsGetChecked, while Latham & Watkins and BakerHostetler advised Truepill on the deal. LetsGetChecked, a...
Seres Therapeutics’ VOWST Asset Purchase Agreement With Nestlé Health Science
Latham & Watkins advised Seres Therapeutics, while Mayer Brown represented Société des Produits Nestlé on the deal. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics...
Otsuka Pharmaceutical’s Acquisition of Jnana Therapeutics
Skadden is advising Otsuka, while Latham & Watkins is advising Jnana on the deal. Nutraceutical and pharmaceutical company Otsuka Holdings Co. Ltd., (Otsuka), announced the definitive...
Concentra’s $529 Million Initial Public Offering
Dechert advised Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. on the transaction, while Latham & Watkins advised the underwriters. Medical Holdings Corporation (“Select...
Nano Dimension’s Acquisition of Desktop Metal
Greenberg Traurig and Sullivan & Worcester are advising Nano Dimension, while Latham & Watkins and Shibolet & Co. are advising Desktop Metal on the deal. Nano...